Amarin NDA For CeNeS Morphine Suppository Planned For Second-Half 2002
Amarin expects to file an NDA for the morphine-releasing rectal suppository Moraxen by second-half 2002.
You may also be interested in...
The European Commission's proposed patent reforms could accelerate the approval of generic drugs by two years.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011